I’m not sure that you understand how it works.

First 26 Last

Share
Profile

Follow
ToH

512 Posts.

27

09/04/19

19:10

Post #: 38066531
Share

Originally posted by chibadedignhk: ↑

General disclaimer: Below is IMO. No benefit at all........

I took most of researched Reports as a Book in order for me to address my knowledge and understanding and I made the researching on Biotech almost over year and it was attracted for me on last year as it's price growth up over Thousand % on website .

Eventually, I need to do my homework and internet researching to compare with other PDT.

IMO.. Buy or not buy is determined by investors as no one force them to do.

For my understanding, Every kind of new product need to carryout the promotion on advertising on newspaper, TV advertisement and other Multimedia or Exhibition to draw people attention as they may not in the Field.

I hope below of my Investigation and Expectation can share with All :-

Shorten from the History of Surgery to NGPDT

Surgery is being applied on Human since few thousand years (BCE) ago. Of coz with the wisdom and talent of Humans keep on development,each of development on Surgery every stage is more sophisticated than before. Unfortunately, during the past period, the surgical Techniques still could not overcome three principal Obstacles as like as bleeding, pain and infection. The other main point the wound is too big and need time to recover.

Until On Year 1984 Dr.John EA Wickham developed the Minimally Inasive Surgery base on this development, there are with 3D and 4D technology available. Now Parts of Surgery are almost taken place as it can minimize the the Principal Obstacles but it is still not enough to handle for Cancer therapy.
I reference to above is let us know the latest Medicine community is now continuously improving, what we can expect is no need to apply any Surgery then can keep our health going well.

For Patient they really concern and want to have a new Break Though therapy potential replacement existing Treatments.

If Photosoft/IVX-P02 also stimulates the body’s immune system to generate a positive immune response to the cancer. That could potentially help to control any recurrence of the disease. In combination with immune-treatment, it could help to protect the patient from the spread of cancer and that could use and helpful for all cancers in early stage.

My expectation is this NGPDT Photosoft^TM can bring us another Milestone on Medicine.

Cheer !

Expand

I’m not sure that you understand how it works.

IVX Price at posting: 2.4¢ Sentiment: None Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

CTT

Cettire shares jump on FY24 revenue growth up 80% vs pcp – but stock still badly bruised

ATH

Trial for Alterity's neurodegenerative drug ATH434 shows reduced disability

NWC

New World Resources inks complete PFS for Antler Copper Project in Arizona, USA

LRL

Labyrinth shares rocket by 219% on news of Comet Vale and Vivien gold project acquisitions

AI stocks: What to expect in 2024-25

There are more pages in this discussion • 19 more messages in this thread...

First 26 Last

Add IVX (ASX) to my watchlist

(20min delay)
Last 0.4¢		Change 0.000(0.00%)		Mkt cap ! $26.41M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
30	16162043	0.4¢

Sellers (Offers)

Price($)	Vol.	No.
0.5¢	7630737	29

View Market Depth

No.	Vol.	Price($)
30	16162043	0.004
22	18034337	0.003
5	4900000	0.002
8	13200000	0.001
0	0	0.000

Price($)	Vol.	No.
0.005	7630737	29
0.006	3871276	12
0.007	3518975	7
0.008	4842200	6
0.009	2650299	8

Last trade - 16.12pm 17/07/2024 (20 minute delay)

IVX (ASX) Chart

Day chart unavailable

I’m not sure that you understand how it works.

Cettire shares jump on FY24 revenue growth up 80% vs pcp – but stock still badly bruised

Trial for Alterity's neurodegenerative drug ATH434 shows reduced disability

New World Resources inks complete PFS for Antler Copper Project in Arizona, USA

Labyrinth shares rocket by 219% on news of Comet Vale and Vivien gold project acquisitions

AI stocks: What to expect in 2024-25

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

I’m not sure that you understand how it works.

Top Stories

Cettire shares jump on FY24 revenue growth up 80% vs pcp – but stock still badly bruised

Trial for Alterity's neurodegenerative drug ATH434 shows reduced disability

New World Resources inks complete PFS for Antler Copper Project in Arizona, USA

Labyrinth shares rocket by 219% on news of Comet Vale and Vivien gold project acquisitions

AI stocks: What to expect in 2024-25

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News